J. Goldman & CO LP Axsome Therapeutics, Inc. Transaction History

J. Goldman & CO LP

$3.21 Billion
Q3 2024

A detailed history of J. Goldman & CO LP transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, J. Goldman & CO LP holds 8,279 shares of AXSM stock, worth $720,355. This represents 0.02% of its overall portfolio holdings.

Number of Shares

8,279

Previous 8,336 0.68%

Holding current value

$720,355

Previous $671,000 10.73%

% of portfolio

0.02%

Previous 0.02%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$78.93 - $95.84 $4,499 - $5,462	-57 Reduced 0.68%	8,279 $743,000
Q2 2024 Aug 14, 2024	SELL	$65.72 - $80.5 $36,803 - $45,080	-560 Reduced 6.29%	8,336 $671,000
Q1 2024 May 15, 2024	BUY	$69.39 - $97.64 $231,831 - $326,215	3,341 Added 60.14%	8,896 $709,000
Q4 2023 Feb 14, 2024	SELL	$57.42 - $83.61 $2.77 Million - $4.03 Million	-48,256 Reduced 89.68%	5,555 $442,000
Q3 2023 Nov 14, 2023	BUY	$69.25 - $82.21 $2.62 Million - $3.11 Million	37,865 Added 237.46%	53,811 $3.76 Million
Q2 2023 Aug 14, 2023	SELL	$58.41 - $90.35 $2.71 Million - $4.19 Million	-46,405 Reduced 74.43%	15,946 $1.15 Million
Q1 2023 May 15, 2023	BUY	$58.39 - $75.0 $3.48 Million - $4.47 Million	59,652 Added 2210.15%	62,351 $3.85 Million
Q4 2022 Feb 14, 2023	BUY	$39.94 - $79.72 $107,798 - $215,164	2,699 New	2,699 $208,000
Q1 2020 May 15, 2020	SELL	$41.2 - $101.31 $154,623 - $380,216	-3,753 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$16.71 - $106.24 $127,397 - $809,973	-7,624 Reduced 67.01%	3,753 $388,000
Q3 2019 Nov 14, 2019	BUY	$20.24 - $29.16 $34,387 - $49,542	1,699 Added 17.56%	11,377 $230,000
Q2 2019 Aug 14, 2019	SELL	$13.46 - $25.75 $501,990 - $960,346	-37,295 Reduced 79.4%	9,678 $249,000
Q1 2019 May 14, 2019	BUY	$2.63 - $16.34 $123,538 - $767,538	46,973 New	46,973 $668,000

Others Institutions Holding AXSM

# of Institutions

325

Shares Held

37.7M

Call Options Held

912K

Put Options Held

855K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.73B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on J. Goldman & CO LP with notifications on news.

Account